AZD6280

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2011-2015
01220112015

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Sedation, dependence, and abuse liability limit the use of non-selective γ-aminobutyric acid (GABAA) receptor positive modulators… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2015
2015
OBJECTIVE AZD6280 is a novel γ-aminobutyric acid A receptor modulator with higher in vitro efficacy at the α2,3 subtypes as… (More)
Is this relevant?
2015
2015
Compounds with selectivity for GABAA receptor subtypes may differ significantly from nonselective benzodiazepines in their… (More)
  • figure 1
  • table 1
Is this relevant?
2013
2013
An ongoing challenge of drug metabolite profiling is to detect and identify unknown or low-level metabolites in complex… (More)
Is this relevant?
2011
2011
4-Amino-8-(2,5-dimethoxyphenyl)-N-propylcinnoline-3-carboxamide (AZD6280) is a selective GABA-A(α2/3) receptor modulator under… (More)
Is this relevant?